Navigation Links
Forging the Way Ahead to Better Drug Development for NASH Patients, Upcoming Webinar Hosted by Xtalks
Date:8/14/2019

Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research in a live session on Tuesday, September 10, 2019 at 1pm EDT to learn about two common imaging methods in NAFLD/NASH to aid with early disease diagnosis, risk stratification and effective management.

NAFLD is the most common diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided into simple steatosis and NASH.

Patients with NAFLD are at risk of steatohepatitis and progressive liver fibrosis culminating in cirrhosis, typically over a period of decades.

Although liver biopsy is currently the gold standard for diagnosing progressive NASH, it has many drawbacks, such as sampling error, cost and risk of complications. Furthermore, it is not realistic to perform liver biopsies on all NAFLD patients.

The limitations of liver biopsy have driven a search for non-invasive NAFLD screening and risk stratification methods. Since advanced fibrosis has been proven to be prognostic of poor outcomes in NAFLD, multiple surrogate fibrosis markers have been studied, including imaging methods.

The two most prevalent imaging techniques to examine NAFLD and NASH patients are:

  •     Magnetic resonance elastography (MRE) — a technique that builds upon magnetic resonance imaging (MRI) to determine the stiffness of the liver, which can be used to determine the degree of fibrosis
  •     Proton density fat fraction (PDFF) — an MRI technique that can accurately determine the amount of fat in the liver (steatosis)

In this free webinar, the featured speaker will discuss these imaging methods, how they may be used for NAFLD/NASH screening, diagnosis & risk stratification, and other imaging techniques that may provide value in NAFLD/NASH patients.

For more information or to register for this event, visit Imaging for NAFLD/NASH: Current State and Future Trends.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Candice Tang
Tel: +1 (416) 977-6555 ext 400
Email: ctang@xtalks.com

Read the full story at https://www.prweb.com/releases/forging_the_way_ahead_to_better_drug_development_for_nash_patients_upcoming_webinar_hosted_by_xtalks/prweb16500313.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Forging iron women
2. 7 new GSA Bulletin articles posted online ahead of print
3. Staying ahead of Huntingtons disease
4. JCI online ahead of print table of contents for March 25, 2014
5. JCI online ahead of print table of contents for April 8, 2014
6. JCI online ahead of print table of contents for April 17, 2014
7. JCI online ahead of print table of contents for May 1, 2014
8. JCI online ahead of print table of contents for May 27, 2014
9. JCI online ahead of print table of contents for June 2, 2014
10. Racing ahead of disease outbreaks: $12 million in new research grants
11. Cybrexa Therapeutics Expands Scientific Advisory Board Ahead of IND Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2020)... ... August 12, 2020 , ... ... that are ideal for public health agencies of all sizes. With a focus ... helping at-risk individuals find appropriate health care, Mosio helps public health departments automate ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval from ... and ProText™, making them the first Wharton’s jelly allografts to be assigned a Q ... company’s solutions are the first Wharton’s jelly allograft product to be recognized as a ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... product portfolio with a near term focus on Type 2 diabetes and associated ... experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin will ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... Diversified Technologies, Inc. has introduced a full ... drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar Transmitter Systems ... push-pull configuration; yielding fast fall time for a capacitive load. These all solid-state ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... today announced the release of its signature product called Beacon - a ... and other field medical professionals. , Beacon helps MSLs streamline communication ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , a leading ... food industries, is pleased to announce that Charles Galea has joined its clinical ... Charles is an accomplished and results-driven sales executive with over 10 years of ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in Mexico ... patient's condition, treatment may be offered IV, intrathecal or with a combination. , A ... and the incidence continues to increase as individuals live longer. There is no cure, ...
Breaking Biology Technology: